Related Experiment Videos
Insights
Pediatric myasthenia gravis can be treated effectively. Prostigmine and steroids offer remission for children with myasthenic symptoms, with some achieving remission without prolonged treatment.
Area of Science:
- Neurology
- Pediatrics
- Clinical Medicine
Background:
- Myasthenia gravis presents with fluctuating muscle weakness.
- Pediatric cases require specific diagnostic and management approaches.
Purpose of the Study:
- To evaluate treatment outcomes in children diagnosed with myasthenic symptoms.
- To assess the efficacy of prostigmine and steroid therapy in pediatric myasthenia gravis.
Main Methods:
- A retrospective review of twelve pediatric patients with myasthenic symptoms over six years.
- Analysis of treatment responses including prostigmine, steroids, and spontaneous remission.
Main Results:
- Five children achieved complete remission with prostigmine.
- Three children responded well to a combination of prostigmine and steroids.
- Two children showed symptom relief without extended treatment.
- Two patients were lost to follow-up; thymectomy was not performed.
Conclusions:
- Prostigmine and steroid therapies are effective in managing pediatric myasthenia gravis.
- Some children may achieve remission with conservative or short-term treatment.
- Further research into long-term outcomes and optimal treatment strategies is warranted.
Abstract:
Twelve children with myasthenic symptoms were seen over a period of 6 years. The age of onset of symptoms ranged from 6 months to 9 years. On followup for a mean period of 4.25 years, (longest followup was 9 years) five children went into complete remission of symptoms after treatment with prostigmine; three children responded to prostigmine and steroids; two children were relieved of symptoms without prolonged treatment and the remaining two children could not be followed up. Thymectomy was not advised in any patient.